CLINICAL_TRIALS
trial_result
· 2012-10-30
Clinical Trial Update: Kaletra: Therapy With Double Protease Inhibitors
Summary
Completed results for Kaletra (lopinavir/ritonavir) therapy using double protease inhibitors in HIV treatment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Human Immunodeficiency Virus | Status: COMPLETED | Results posted: 2012-10-30